Login Register
English
0

Cart

$ 0

Blocking the LRH-1/LCN2 axis by ML-180, an LRH-1 inverse agonist, ameliorates osteoarthritis via inhibiting the MAPK pathway.(A25112-5.600)

Date:2025-07-25 Views:18